Market Data 
Markets
Replies to post #57749 on Cannabis Science Inc (fka CBIS)
04/05/12 2:16 AM
Nine U.S. medical specialty societies representing 374,000 physicians have put together a list of "Five Things Physicians and Patients Should Question."
American Society of Clinical Oncology:Don't use cancer-directed therapy for solid tumor patients with the following characteristics: low performance status (3 or 4), no benefit from prior evidence-based interventions, not eligible for a clinical trial, and no strong evidence supporting the clinical value of further anti- cancer treatment.
Don't perform PET, CT, and radionuclide bone scans in the staging of early prostate cancer at low risk for metastasis.
Don't perform PET, CT, and radionuclide bone scans in the staging of early breast cancer at low risk for metastasis.
Don't perform surveillance testing (biomarkers) or imaging (PET, CT, and radionuclide bone scans) for asymptomatic individuals who have been treated for breast cancer with curative intent.
Don't use white cell stimulating factors for primary prevention of febrile neutropenia for patients with less than 20 percent risk for this complication
AI
